All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

 
13x13x1 READ MORE
Read the Investors Guide To Newly Emerging Marijuana Markets 
LEARN MORE
600x300
Canopy Growth Adds Manitoba-Based Licensed Producer Delta 9 to the CraftGrow Family

Canopy Growth Corporation (TSX: WEED) enters into a distribution agreement with Winnipeg-based Delta 9 Cannabis Inc. (TSXV: NINE). Delta 9 will offer their well-established cannabis products through Canopy Growth's curated CraftGrow line via Tweed Main Street's online store, alongside other high-quality cannabis varieties grown by a diverse set of producers.

13x13x1 READ MORE
600x300
CannaRoyalty Signs Binding Term Sheets to Acquire Two Leading California Cannabis Companies

CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) announces that it has executed a binding term sheet to acquire Kaya Management Inc.which is the exclusive manufacturer and license holder of rights for Bhang® brand vaporizer products in California.

13x13x1 READ MORE
600x300
Organigram Announces $50 Million Bought Deal For Incremental 40,000 kg/year Expansion

Organigram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) announces that it has entered into a letter of engagement with Eight Capital under which Eight Capital has agreed to purchase, together with a syndicate of Underwriters 14,285,715 units of the Company on a "bought deal" basis pursuant to the filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $3.50 for gross proceeds of $50,000,003..

13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 
 
32x32x1   32x32x2   32x32x3
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2018, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.